BIOMAT Database Logo BIOMAT Database Logo

[Investigations on chloramphenicol availability in ophthalmic lamellae]. 1979

E Gafitanu, and V Zvorişteanu, and I Matei, and S Braha, and V Dorneanu, and B Awe

UI MeSH Term Description Entries
D009883 Ophthalmic Solutions Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS. Eye Drop,Eyedrop,Eyedrops,Ophthalmic Solution,Eye Drops,Drop, Eye,Drops, Eye,Solution, Ophthalmic,Solutions, Ophthalmic
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D002701 Chloramphenicol An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) Cloranfenicol,Kloramfenikol,Levomycetin,Amphenicol,Amphenicols,Chlornitromycin,Chlorocid,Chloromycetin,Detreomycin,Ophthochlor,Syntomycin
D002845 Chromatography Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. Chromatographies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D015818 Eye Infections, Bacterial Infections in the inner or external eye caused by microorganisms belonging to several families of bacteria. Some of the more common genera found are Haemophilus, Neisseria, Staphylococcus, Streptococcus, and Chlamydia. Bacterial Eye Infections,Ocular Infections, Bacterial,Bacterial Ocular Infections,Infections, Bacterial Eye,Infections, Bacterial Ocular,Bacterial Eye Infection,Bacterial Ocular Infection,Eye Infection, Bacterial,Infection, Bacterial Eye,Ocular Infection, Bacterial

Related Publications

E Gafitanu, and V Zvorişteanu, and I Matei, and S Braha, and V Dorneanu, and B Awe
Chloramphenicol ophthalmic formulations.
October 1980, The Medical letter on drugs and therapeutics,
E Gafitanu, and V Zvorişteanu, and I Matei, and S Braha, and V Dorneanu, and B Awe
[Topical ophthalmic chloramphenicol].
January 1996, Duodecim; laaketieteellinen aikakauskirja,
E Gafitanu, and V Zvorişteanu, and I Matei, and S Braha, and V Dorneanu, and B Awe
Prescribing and sale of ophthalmic chloramphenicol following reclassification to over-the-counter availability.
October 2010, The International journal of pharmacy practice,
E Gafitanu, and V Zvorişteanu, and I Matei, and S Braha, and V Dorneanu, and B Awe
[Production of ophthalmic lamellae with collagen].
January 1988, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
E Gafitanu, and V Zvorişteanu, and I Matei, and S Braha, and V Dorneanu, and B Awe
Ophthalmic use of chloramphenicol.
December 1987, Lancet (London, England),
E Gafitanu, and V Zvorişteanu, and I Matei, and S Braha, and V Dorneanu, and B Awe
[Biological availability of chloramphenicol].
January 1974, Archivos de investigacion medica,
E Gafitanu, and V Zvorişteanu, and I Matei, and S Braha, and V Dorneanu, and B Awe
[Chloramphenicol in ophthalmic practice (author's transl)].
November 1976, Klinische Monatsblatter fur Augenheilkunde,
E Gafitanu, and V Zvorişteanu, and I Matei, and S Braha, and V Dorneanu, and B Awe
Blood dyscrasias and topical ophthalmic chloramphenicol.
June 1993, American journal of ophthalmology,
E Gafitanu, and V Zvorişteanu, and I Matei, and S Braha, and V Dorneanu, and B Awe
[Investigations on the stability of chloramphenicol ointments & suppositories].
January 1958, Journal de pharmacie de Belgique,
E Gafitanu, and V Zvorişteanu, and I Matei, and S Braha, and V Dorneanu, and B Awe
[Pharmacological research on ophthalmic drug lamellae containing gentamycin sulfate in laboratory and agricultural animals].
January 1987, Veterinarno-meditsinski nauki,
Copied contents to your clipboard!